Microbial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance Patterns
暂无分享,去创建一个
Antoni Torres | A. Torres | I. Martín-Loeches | C. Cillóniz | C. García-Vidal | Ignacio Martin-Loeches | Catia Cilloniz | A. San José | Carolina Garcia-Vidal | Alicia San Jose
[1] I. Latorre,et al. Usefulness of pneumococcal antigen detection in pleural fluid samples by immunochromatographic assay for diagnosis of pneumococcal pneumonia. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[2] Garrett E. Schramm,et al. Pseudomonas aeruginosa Nosocomial Pneumonia: Impact of Pneumonia Classification , 2015, Infection Control & Hospital Epidemiology.
[3] J. M. Porcel,et al. A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] A. Bilbao,et al. Etiology of community-acquired pneumonia in a population-based study: Link between etiology and patients characteristics, process-of-care, clinical evolution and outcomes , 2012, BMC Infectious Diseases.
[5] J. Rello,et al. Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study , 2016, European Journal of Clinical Microbiology & Infectious Diseases.
[6] E. Walsh,et al. Respiratory syncytial virus infection in adult populations. , 2012, Infectious disorders drug targets.
[7] M. de Martino,et al. Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: a prospective, observational study of children and adolescents with proven pneumococcal infection. , 2009, Clinical therapeutics.
[8] Peggy Cruse,et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] Mathias W Pletz,et al. Detection of Pneumonia Associated Pathogens Using a Prototype Multiplexed Pneumonia Test in Hospitalized Patients with Severe Pneumonia , 2014, PloS one.
[10] J. Nicolás,et al. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia. , 1999, American journal of respiratory and critical care medicine.
[11] J. M. Porcel,et al. Evaluation of the polymerase chain reaction method for detection of Streptococcus pneumoniae DNA in pleural fluid samples. , 2002, Chest.
[12] A. Torres,et al. Community-acquired pneumonia in outpatients: aetiology and outcomes , 2012, European Respiratory Journal.
[13] D. Cook,et al. Endotracheal aspiration in the diagnosis of ventilator-associated pneumonia. , 2000, Chest.
[14] F. Tubau,et al. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. , 2004, Archives of internal medicine.
[15] Jordi Rello,et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. , 2002, Chest.
[16] Ronald N. Jones. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] D. Fleming,et al. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study , 2001, The Lancet.
[18] The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis , 2013, European Journal of Clinical Microbiology & Infectious Diseases.
[19] P. Tulkens,et al. Multidrug-Resistant Streptococcus pneumoniae Infections , 2012, Drugs.
[20] G. Barlow,et al. Reducing door-to-antibiotic time in community-acquired pneumonia: controlled before-and-after evaluation and cost-effectiveness analysis , 2006, Thorax.
[21] P. Wyer,et al. Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia. , 2007, Annals of emergency medicine.
[22] C. Stuart-harris,et al. Atypical Pneumonia* , 1950, British medical journal.
[23] S. Osajima. [VIRAL PNEUMONIA]. , 1963, Naika. Internal medicine.
[24] A. Torres,et al. Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis , 2011, Critical care.
[25] D. Chung,et al. Community-acquired pneumonia requiring hospitalization among U . S . adults , 2016 .
[26] M. Niederman,et al. Community-acquired pneumonia related to intracellular pathogens , 2016, Intensive Care Medicine.
[27] J. Sollet,et al. [Interest of real-time PCR Xpert MRSA/SA on GeneXpert(®) DX System in the investigation of staphylococcal bacteremia]. , 2011, Pathologie-biologie.
[28] Brian A. King,et al. Current Cigarette Smoking Among Adults — United States, 2005–2013 , 2014, MMWR. Morbidity and mortality weekly report.
[29] Brian A. King,et al. Current cigarette smoking among adults - United States, 2011. , 2012, MMWR. Morbidity and mortality weekly report.
[30] M. Postma,et al. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis. , 2015, Vaccine.
[31] R. Dittus,et al. Influenza– and Respiratory Syncytial Virus–Associated Morbidity and Mortality in the Nursing Home Population , 2003, Journal of the American Geriatrics Society.
[32] T. Welte,et al. Clinical and economic burden of community-acquired pneumonia among adults in Europe , 2010, Thorax.
[33] M. Niederman,et al. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa. , 2016, Chest.
[34] R. Gaynes,et al. Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States , 2000, Infection Control & Hospital Epidemiology.
[35] F. Blasi,et al. Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. , 2013, Chest.
[36] A. Liapikou,et al. Polymicrobial intensive care unit-acquired pneumonia: prevalence, microbiology and outcome , 2015, Critical Care.
[37] A. Torres,et al. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms. , 2015, The Journal of infection.
[38] A. Puren,et al. Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: epidemiology and factors associated with fatal cases. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[39] Diego Viasus,et al. Características clínicas y pronóstico de la neumonía adquirida en la comunidad causada por Staphylococcus aureus resistente a la meticilina , 2014 .
[40] R. Rodríguez-Roisín,et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. , 1990, The American review of respiratory disease.
[41] Jongyoun Yi,et al. Clinical utility of rapid pathogen identification using matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry in ventilated patients with pneumonia: A pilot study , 2016, Respirology.
[42] G. Tillotson,et al. Geographically-based evaluation of multidrug resistance trends among Streptococcus pneumoniae in the USA: findings of the FAST surveillance initiative (2003-2004). , 2006, International journal of antimicrobial agents.
[43] M. Niederman,et al. Nosocomial pneumonia: lessons learned. , 2013, Critical care clinics.
[44] S. Zakynthinos,et al. Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria , 2005, Intensive Care Medicine.
[45] Mauricio Valencia,et al. Ventilator-associated pneumonia , 2009, Current opinion in critical care.
[46] M. Kollef,et al. Economic Impact of Ventilator-Associated Pneumonia in a Large Matched Cohort , 2012, Infection Control & Hospital Epidemiology.
[47] J. King,et al. MATERNAL MORTALITY IN THE UNITED STATES , 1951, American journal of public health.
[48] J. Ebbert,et al. Respiratory Syncytial Virus Pneumonitis in Immunocompromised Adults: Clinical Features and Outcome , 2005, Respiration.
[49] E. Arias,et al. Mortality in the United States, 2014. , 2015, NCHS data brief.
[50] A. Bourdin,et al. Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor , 2004, European Respiratory Journal.
[51] D. Sinclair,et al. Nosocomial pneumonia in the intensive care unit. , 1994, British journal of hospital medicine.
[52] R. Vainionpää,et al. Diagnostic Value of Bronchoalveolar Lavage in Community-acquired Pneumonia in a Routine Setting: A Study on Patients Treated in a Finnish University Hospital , 2004, Scandinavian journal of infectious diseases.
[53] F. Baquero,et al. Factors impacting on length of stay and mortality of community-acquired pneumonia. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[54] S. Dowell,et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. , 1996, The Journal of infectious diseases.
[55] 古谷 良輔,et al. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. , 2008, American journal of respiratory and critical care medicine.
[56] J. Rello,et al. Microbiological testing and outcome of patients with severe community-acquired pneumonia. , 2003, Chest.
[57] J. Dorca,et al. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[58] Jae-Hoon Song,et al. Respiratory infections due to drug-resistant bacteria. , 2010, Infectious disease clinics of North America.
[59] F. Blasi,et al. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective , 2013, Thorax.
[60] E. Maltezos,et al. A prospective study of the diagnostic utility of sputum Gram stain in pneumonia. , 2009, The Journal of infection.
[61] B. Cao,et al. Etiological analysis and predictive diagnostic model building of community-acquired pneumonia in adult outpatients in Beijing, China , 2013, BMC Infectious Diseases.
[62] T. Welte,et al. Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors , 2009, European Respiratory Journal.
[63] Alan D. Lopez,et al. The Global Burden of Disease Study , 2003 .
[64] K. Edwards,et al. Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease. , 2002, Archives of internal medicine.
[65] R. Wunderink,et al. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. , 2001, Respiratory medicine.
[66] J. Sollet,et al. Intérêt de la PCR temps réel Cepheid Xpert SAMR/SA sur GeneXpert® DX System dans la prise en charge de la bactériémie à staphylocoque , 2011 .
[67] M. Fujimura,et al. Severe community-acquired pneumonia in an intensive care unit: risk factors for mortality. , 2005, Internal medicine.
[68] M. Niederman,et al. Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis , 2015, European Respiratory Journal.
[69] J. Dorca,et al. Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes , 2009, Thorax.
[70] J. Dorca,et al. Declining mortality among hospitalized patients with community-acquired pneumonia. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[71] C. Dolea,et al. World Health Organization , 1949, International Organization.
[72] Brian A. King,et al. Current Cigarette Smoking Among Adults — United States, 2016 , 2015, MMWR. Morbidity and mortality weekly report.
[73] R. Rodríguez-Roisín,et al. Severe community-acquired pneumonia. Epidemiology and prognostic factors. , 1991, The American review of respiratory disease.
[74] Jay Steingrub,et al. International study of the prevalence and outcomes of infection in intensive care units , 2009 .
[75] T. Welte,et al. Nosocomial pneumonia in the intensive care unit acquired by mechanically ventilated versus nonventilated patients. , 2010, American journal of respiratory and critical care medicine.
[76] A. Palmu,et al. Evaluation of the BinaxNOW® Streptococcus pneumoniae antigen test on fresh, frozen and concentrated urine samples in elderly patients with and without community-acquired pneumonia. , 2016, Journal of microbiological methods.
[77] 韩旭东,et al. Viral pneumonia , 2004 .
[78] F. Blasi,et al. Atypical pathogens and respiratory tract infections , 2004, European Respiratory Journal.
[79] J. Lynch,et al. Streptococcus pneumoniae: Does Antimicrobial Resistance Matter? , 2009, Seminars in respiratory and critical care medicine.
[80] N. Wellinghausen,et al. Rapid detection of Staphylococcus aureus bacteremia and methicillin resistance by real-time PCR in whole blood samples , 2009, European Journal of Clinical Microbiology & Infectious Diseases.
[81] C. Jaca,et al. Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: incidence, clinical presentation and factors associated with severity during hospital stay , 2010, Infection.
[82] A. Conway Morris,et al. Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[83] J. Rello,et al. Ventilator-associated pneumonia: European Task Force on ventilator-associated pneumonia Chairmen of the Task Force: A. Torres and J. Carlet , 2001 .
[84] G. Sarosi,et al. The role of atypical pathogens in community-acquired pneumonia. , 2001, The Medical clinics of North America.
[85] S. Teramoto,et al. Update on the pathogenesis and management of pneumonia in the elderly-roles of aspiration pneumonia. , 2015, Respiratory investigation.
[86] M. Kollef,et al. A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. , 2000, Chest.
[87] M. Wolff,et al. Incidence and outcome of polymicrobial ventilator-associated pneumonia. , 2002, Chest.
[88] J. Carlet,et al. Ventilator-associated pneumonia. European Task Force on ventilator-associated pneumonia. , 2001, The European respiratory journal.
[89] C. Esquinas,et al. Microbial aetiology of community-acquired pneumonia and its relation to severity , 2011, Thorax.
[90] Bernadette A. Thomas,et al. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.
[91] Bernadette A. Thomas,et al. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.
[92] J. Bartlett,et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[93] M. Cetron,et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. , 2000, The New England journal of medicine.
[94] R. Albert,et al. The Effect of Macrolide Resistance on the Presentation and Outcome of Patients Hospitalized for Streptococcus pneumoniae Pneumonia. , 2015, American journal of respiratory and critical care medicine.
[95] A. Anzueto,et al. Economic Burden of Ventilator-Associated Pneumonia Based on Total Resource Utilization , 2008, Infection Control & Hospital Epidemiology.